Literature DB >> 4923003

Weight changes with schizophrenic psychosis and psychotropic drug therapy.

J M Holden, U P Holden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4923003     DOI： 10.1016/S0033-3182(70)71576-4

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  5 in total

1.  Weight gain and new onset diabetes associated with olanzapine and risperidone.

Authors:  Wildon R Farwell; Timothy E Stump; Jane Wang; Eskinder Tafesse; Gilbert L'Italien; William M Tierney
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

Review 2.  Benzodiazepines for schizophrenia.

Authors:  Markus Dold; Chunbo Li; Magdolna Tardy; Vesal Khorsand; Donna Gillies; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

3.  Inhibition of foot intake in the rat.

Authors:  N Blavet; F V DeFeudis
Journal:  Neurochem Res       Date:  1982-03       Impact factor: 3.996

Review 4.  Adverse effects of antipsychotic agents. Do newer agents offer advantages?

Authors:  D G Owens
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

Review 5.  The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.

Authors:  Alex T Raben; Victoria S Marshe; Araba Chintoh; Ilona Gorbovskaya; Daniel J Müller; Margaret K Hahn
Journal:  Front Neurosci       Date:  2018-01-22       Impact factor: 4.677
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.